{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:32:13Z","timestamp":1793079133753,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["PNRR MCNT2- 2023-12377846"],"award-info":[{"award-number":["PNRR MCNT2- 2023-12377846"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.yebeh.2026.111261","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:13:46Z","timestamp":1788549226000},"page":"111261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Perampanel in real-world epilepsy setting: results from the PERSICILIA study"],"prefix":"10.1016","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2633-7635","authenticated-orcid":false,"given":"Roberta","family":"Roberti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Politi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Lamanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore Maria","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cottone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0414-1359","authenticated-orcid":false,"given":"Maurizio","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Gammino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylenia","family":"Gazzitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2512-6972","authenticated-orcid":false,"given":"Loretta","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9225-2042","authenticated-orcid":false,"given":"Angelina","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore Maria","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore Lo","family":"Cascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele Lo","family":"Coco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1977-9275","authenticated-orcid":false,"given":"Francesca","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8956-5486","authenticated-orcid":false,"given":"Mariangela","family":"Panebianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Pirrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0813-6091","authenticated-orcid":false,"given":"Giuseppe","family":"Santangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Span\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9932-3226","authenticated-orcid":false,"given":"Lidia","family":"Urso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Zummo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-8123","authenticated-orcid":false,"given":"Emilio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8827-7324","authenticated-orcid":false,"given":"Angelo","family":"Labate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2026.111261_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1182304","article-title":"The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy","volume":"14","author":"Perversi","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2026.111261_b0010","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1080\/14656566.2017.1392509","article-title":"AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives","volume":"18","author":"Di Bonaventura","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.yebeh.2026.111261_b0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/14728222.2014.874416","article-title":"Targeting \u03b1-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy","volume":"18","author":"Citraro","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.yebeh.2026.111261_b0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ane.12099","article-title":"AMPA receptors as a molecular target in epilepsy therapy","author":"Rogawski","year":"2013","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.yebeh.2026.111261_b0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41582-025-01064-z","article-title":"Mechanistic insights into the interaction between epilepsy and sleep","volume":"21","author":"Sheybani","year":"2025","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.yebeh.2026.111261_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00398","article-title":"Circadian-like rhythmicity of extracellular brain glutamate in epilepsy","volume":"11","author":"Sandhu","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2026.111261_b0035","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.seizure.2019.04.019","article-title":"Prevalence of sleep disturbances in people with epilepsy and the impact on quality of life: a survey in secondary care","volume":"69","author":"Gutter","year":"2019","journal-title":"Seizure - Eur J Epilepsy"},{"key":"10.1016\/j.yebeh.2026.111261_b0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yebeh.2016.08.004","article-title":"Sleep quality and daytime sleepiness in patients treated with adjunctive perampanel for focal seizures","volume":"63","author":"Toledo","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111261_b0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.yebeh.2016.10.033","article-title":"Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: further data","volume":"67","author":"Romigi","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111261_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2025.110748","article-title":"Perampanel effects on seizures and sleep quality in people with epilepsy: a prospective multicenter study","volume":"172","author":"Bergamo","year":"2025","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111261_b0055","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40120-024-00618-5","article-title":"Perampanel for treatment of people with a range of epilepsy aetiologies in clinical practice: evidence from the PERMIT extension study","volume":"13","author":"Strzelczyk","year":"2024","journal-title":"Neurol Ther"},{"key":"10.1016\/j.yebeh.2026.111261_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108777","article-title":"The real-world effectiveness and safety of perampanel in Europe: a scoping review","volume":"134","author":"Est\u00e9vez-Mar\u00eda","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111261_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108961","article-title":"Effectiveness and tolerability of adjunctive perampanel in the treatment of pediatric patients with uncontrolled epilepsy: a retrospective, single-center, real-world study","volume":"137","author":"Gao","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111261_b0070","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s40263-021-00831-y","article-title":"Exploring the evidence for broad-spectrum effectiveness of perampanel: a systematic review of clinical data in generalised seizures","volume":"35","author":"Trinka","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2026.111261_b0075","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1517\/14656566.2015.1084504","article-title":"Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis","volume":"16","author":"Palleria","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.yebeh.2026.111261_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116903","article-title":"The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a \u201creal world\u201d context: focus on temporal lobe epilepsy","volume":"415","author":"Pascarella","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2026.111261_b0085","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2026.111261_b0090","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111261_b0095","unstructured":"Fycompa | European Medicines Agency (EMA) 2018. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/fycompa (accessed June 25, 2026)."},{"key":"10.1016\/j.yebeh.2026.111261_b0100","unstructured":"World Health Organization. Defined Daily Dose (DDD) 2024. https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/about-ddd."},{"key":"10.1016\/j.yebeh.2026.111261_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.775781","article-title":"Temporal lobe epilepsy and psychiatric comorbidity","volume":"12","author":"Vinti","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2026.111261_b0110","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/epi4.70068","article-title":"Real\u2010world use of adjunctive perampanel for focal\u2010onset seizures in Italy: a mirroring clinical practice study of perampanel in adults and adolescents (AMPA)","volume":"10","author":"D\u2019Aniello","year":"2025","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2026.111261_b0115","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/epi.17843","article-title":"A real\u2010world comparison among third\u2010generation antiseizure medications: results from the COMPARE study","volume":"65","author":"Roberti","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111261_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1139514","article-title":"Efficacy and tolerability of perampanel in patients with seizures in real-world clinical practice: a systematic review and meta-analysis","volume":"14","author":"Hou","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.yebeh.2026.111261_b0125","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00415-021-10751-y","article-title":"PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice","volume":"269","author":"Villanueva","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2026.111261_b0130","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/epi4.12649","article-title":"Effectiveness of perampanel as the only add\u2010on: retrospective, multicenter, observational real\u2010life study on epilepsy patients","volume":"7","author":"Gasparini","year":"2022","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2026.111261_b0135","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/epi.17631","article-title":"Perampanel for the treatment of people with idiopathic generalized epilepsy in clinical practice","volume":"64","author":"Trinka","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111261_b0140","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/epi.17530","article-title":"Perampanel as precision therapy in rare genetic epilepsies","volume":"64","author":"Nissenkorn","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111261_b0145","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40120-025-00860-5","article-title":"Lacosamide is associated with a higher treatment persistence at 12months than brivaracetam and perampanel despite similar efficacy","volume":"15","author":"Roberti","year":"2026","journal-title":"Neurol Ther"},{"key":"10.1016\/j.yebeh.2026.111261_b0150","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1111\/epi.18091","article-title":"Adjunctive cenobamate in people with focal onset seizures: insights from the Italian expanded access program","volume":"65","author":"Roberti","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111261_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1026836","article-title":"Effectiveness of perampanel in the treatment of pediatric patients with focal epilepsy and ESES: a single-center retrospective study","volume":"13","author":"Yu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.yebeh.2026.111261_b0160","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s10072-025-08785-5","article-title":"Sleep effects in drug-resistant epileptic patients taking perampanel: an observational study","volume":"47","author":"Lamanna","year":"2026","journal-title":"Neurol Sci"},{"key":"10.1016\/j.yebeh.2026.111261_b0165","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s10072-020-04636-7","article-title":"Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study","volume":"42","author":"Labate","year":"2021","journal-title":"Neurol Sci"},{"key":"10.1016\/j.yebeh.2026.111261_b0170","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017171","article-title":"Effectiveness and safety of perampanel in adults with mesial temporal epilepsy: a single-center postmarketing study in Taiwan","volume":"98","author":"Lin","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.yebeh.2026.111261_b0175","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s41999-021-00481-9","article-title":"Adverse drug reactions in older adults: a narrative review of the literature","volume":"12","author":"Zazzara","year":"2021","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.yebeh.2026.111261_b0180","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/17425255.2020.1806236","article-title":"Pharmacokinetic considerations about antiseizure medications in the elderly","volume":"16","author":"Roberti","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.yebeh.2026.111261_b0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00415-025-13591-2","article-title":"Psychiatric and behavioural side effects of antiseizure medications in epilepsy","volume":"273","author":"Lyndon","year":"2025","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2026.111261_b0190","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s40263-022-00955-9","article-title":"Psychobehavioural and cognitive adverse events of anti-seizure medications for the treatment of developmental and epileptic encephalopathies","volume":"36","author":"Strzelczyk","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2026.111261_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108356","article-title":"Risk factors for psychiatric adverse effects associated with perampanel therapy","volume":"124","author":"Yamamoto","year":"2021","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026003823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026003823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:34:32Z","timestamp":1793075672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026003823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":39,"alternative-id":["S1525505026003823"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111261","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perampanel in real-world epilepsy setting: results from the PERSICILIA study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111261"}}